Sponsor pipeline

Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) clinical trial pipeline

Get alerts when Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-09-24 NCT07838987 A Clinical Trial to Evaluate MK-4208/TERN-701 in Healthy Adult Participants… Phase 1 Completed
2026-09-24 NCT07839000 A Clinical Trial to Evaluate [14C]-MK-4208/[14C]-TERN-701 in Healthy Adult Male… Phase 1 Completed

Active trials by phase

Phase 1/2
1

Disease areas by active trials

Chronic Myeloid Leukemia (CML) (1) · Leukemia (1)

Get alerts when Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free